Eiger BioPharmaceuticals

-$0.45 (-7.13%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EIGR and other ETFs, options, and stocks.

About EIGR

Eiger BioPharmaceuticals, Inc. engages in the development and commercialization of foundational therapies for Hepatitis Delta Virus. It is also developing avexitide as a treatment for Post-Bariatric Hypoglycemia.

CEO
David A. Cory
Employees
28
Headquarters
Palo Alto, California
Founded
2008

EIGR Key Statistics

Market Cap
198.95M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
133.12K
High Today
$6.33
Low Today
$5.82
Open Price
$6.32
Volume
389.43K
52 Week High
$13.49
52 Week Low
$5.82

EIGR Earnings

-$0.62
-$0.13
$0.36
$0.85
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Available Nov 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure